Tag: TMB-H

Home / TMB-H

Categories

Pembrolizumab approved for use in any cancer with a high tumor mutational burden

July 2021: The US Food and Medication Administration (FDA) has expanded the indications for pembrolizumab (Keytruda), an immunotherapy drug, to encompass any cancer with a high mutational burden (TMB-...
tmb-h

Scan the code